Related Experiment Video
Updated: Nov 9, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: A systematic review
Eduardo Martinez-Gomez1, Angela McInerney1, Gabriela Tirado-Conte1
1Cardiology Department, Cardiovascular Institute, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Background:
Very few data exist on percutaneous mitral valve repair (PMVr) in unstable patients with concomitant moderate-severe mitral regurgitation (MR). The purpose of this systematic review was to evaluate baseline characteristics, management and clinical outcomes of critically ill patients undergoing PMVr with MitraClip.
Methods:
We conducted a systematic review of the published data on MitraClip from its first use in 2003 to December 2020. Studies referring to critically ill patients in cardiogenic shock or acute refractory pulmonary edema were included. A total of 40 publications including 254 patients with significant MR (Grade 4 in 91%) were included.
Results:
Mean age was 70 ± 12 years with mean Euroscore II and STS of 21 ± 13 and 20.5 ± 16, respectively. Clinical presentation was with cardiogenic shock and acute myocardial infarction in 72.8 and 60.0% of patients, respectively. Device success was achieved in 238 (93.7%) patients with a significant reduction in MR (Grade ≤ 2 in 91.8%, p < .001). The median weaning time from the procedure, to discontinuation of mechanical circulatory or respiratory support, was 2 days (IQR 1-4), with an in-hospital mortality and non-fatal complication rate of 12.6 and 9.1%, respectively. Kaplan-Meier curves estimated an overall mortality rate of 39.1% at 12-month follow-up, with persistent reduction in MR severity for survivors (Grade ≤ 2 in 81.3%) and one case of mitral valve reintervention.
Conclusions:
Percutaneous mitral valve repair with MitraClip device is a technically feasible and potentially viable management option in high-risk patients with cardiogenic shock or refractory pulmonary edema and concomitant moderate-severe MR. Prospective trials are required to confirm these findings, and definitively determine the value of MitraClip in hemodynamically unstable patients.
Insights
Percutaneous mitral valve repair using MitraClip is feasible in critically ill patients with severe mitral regurgitation. This approach shows promising results, including reduced regurgitation and shorter support durations, though further trials are needed.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Limited data exist on percutaneous mitral valve repair (PMVr) in hemodynamically unstable patients.
- Moderate-to-severe mitral regurgitation (MR) poses significant risks in critically ill individuals.
Purpose of the Study:
- To systematically review the characteristics, management, and outcomes of critically ill patients undergoing PMVr with the MitraClip device.
- To evaluate the efficacy and safety of MitraClip in high-risk patients with severe MR.
Main Methods:
- Systematic review of publications from 2003 to December 2020.
- Inclusion criteria: critically ill patients in cardiogenic shock or acute refractory pulmonary edema with significant MR.
- Analysis of 40 publications involving 254 patients.
Main Results:
- High device success rate (93.7%) with significant MR reduction (91.8% to ≤Grade 2).
- Median weaning time from support was 2 days; in-hospital mortality was 12.6%.
- 12-month overall mortality was 39.1%, with persistent MR reduction in survivors.
Conclusions:
- MitraClip is a technically feasible and potentially viable option for high-risk patients with severe MR and hemodynamic instability.
- Prospective trials are necessary to confirm these findings and establish MitraClip's definitive value in this population.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction
Mitral Regurgitation II: Clinical Features and Diagnostic Tests

